Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
24 h post- GU induction, rats were given pantoprazole dissolved in D.W
26-WEEK TRIAL Clinical Trial Identifier: NCT02580591 Trial name: Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients with T1DM (EASE-3) Diabetes type: Type 1 diabetes What its testing: This trial will assess the efficacy, safety, tolerability, and pharmacokinetics (how a drug is metabolized by the body) of three doses of Jardiance as a supplement to insulin in people with type 1 diabetes
You do need a valid prescription from a licensed clinician
M., Badur, M
Dahl D, Onishi Y, Norwood P et al (2022) Effect of subcutaneous tirzepatide vs placebo added to titrated Insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial
US$ 22.87
US$ 29.23
US$ 29.70
US$ 26.27
US$ 21.11
US$ 21.78
